The effect of meropenem versus piperacillin-tazobactam in critically ill patients with sepsis and septic shock()

BACKGROUND: Antibiotics are a popular and efficient treatment for sepsis and septic shock. However, there is presently little proof of Meropenem with piperacillin-therapeutic tazobactam's benefits. METHODS: From January 1, 2010 to January 1, 2021, we treated a total of 1244 patients with sepsis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yang, Liu, Yu, Wang, Jixia, Cui, Can
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245158/
https://www.ncbi.nlm.nih.gov/pubmed/37292309
http://dx.doi.org/10.1016/j.heliyon.2023.e16542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245158/
https://www.ncbi.nlm.nih.gov/pubmed/37292309
http://dx.doi.org/10.1016/j.heliyon.2023.e16542

Ejemplares similares